Riboflavin Treatment in Genetically Proven Brown-Vialetto-Van Laere Syndrome

Area of Science:

• Neurology
• Genetics
• Rare Diseases

Background:

• Brown-Vialetto-Van Laere (BVVL) syndrome is a rare, autosomal-recessive motor neuron disorder.
• It exists on a spectrum with Fazio-Londe syndrome.
• Genetic mutations in intestinal riboflavin transporter genes are implicated in BVVL syndrome.

Observation:

• A pediatric patient presented with symptoms consistent with BVVL syndrome.
• Genetic testing confirmed the diagnosis of BVVL syndrome in the child.
• The patient received prompt treatment with riboflavin.

Findings:

• The child with genetically confirmed BVVL syndrome showed a positive response to riboflavin therapy.
• Early intervention with riboflavin led to favorable clinical results.

Implications:

• This case highlights the efficacy of riboflavin treatment for Brown-Vialetto-Van Laere syndrome.
• Early diagnosis and prompt riboflavin supplementation are crucial for managing this rare genetic disorder.
• Further research into riboflavin transporter gene mutations and their role in motor neuron diseases is warranted.